Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000205607 | SCV000260368 | benign | Jeune thoracic dystrophy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000500731 | SCV000594463 | likely benign | not specified | 2016-04-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000500731 | SCV000713948 | benign | not specified | 2018-02-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001801494 | SCV002049784 | benign | Asphyxiating thoracic dystrophy 3 | 2023-11-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001795331 | SCV004131359 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | DYNC2H1: BP4, BP7, BS1, BS2 |
Breakthrough Genomics, |
RCV001795331 | SCV005217494 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001795331 | SCV002034297 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000500731 | SCV002038076 | benign | not specified | no assertion criteria provided | clinical testing |